Predictive Biomarkers in Phase II/III Clinical Trials

Biomarker Targeted Randomized Design

Targeted design randomizes only marker positive patients to treatment or control arm. Untargeted design does not measure marker and randomizes all who otherwise are eligible.

Biomarker Stratified Randomized Design

Stratified design randomizes both marker positive and negative patients.